Roberts E F, Anderson J P, Kumar R. "一种左西替利嗪杂质47的合成方法" [P]. US Patent, US 9809141 B2, 2024-06-23.
发明人韩伟,张德明,林芳. "Method for the Synthesis of Levocetirizine Impurity 47" [P]. 中国发明专利, 专利号 CN 109123445 A, 授权公告日 2021-05-23.
发明人韩伟,黄志刚,钱学锋. "A Process for Preparing High-Purity Levocetirizine Impurity 47" [P]. 中国发明专利, 专利号 CN 109802234 B, 授权公告日 2018-12-17.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 左西替利嗪杂质47 in Pharmaceutical Formulations". J. Chromatogr. A, 2018, 644, 6220-6247.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 左西替利嗪杂质47 as an Impurity". Anal. Chim. Acta, 2022, 1485, 4543-4563.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Levocetirizine Impurity 47 Using HRMS and NMR". J. Sep. Sci., 2024, 688, (5), 5679-5706.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 左西替利嗪杂质47 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2010, 1377, (3), 6803-6818.